Home › Compare › VINCW vs VICI

VINCW vs VICI: Dividend Comparison 2026

VINCW yields 124.22% · VICI yields 6.57%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VINCW wins by $9.02M in total portfolio value
10 years
VINCW
VINCW
● Live price
124.22%
Share price
$1.61
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$10.01M
Annual income
$3,875,023.48
Full VINCW calculator →
VICI
VICI Properties Inc.
● Live price
6.57%
Share price
$27.12
Annual div
$1.78
5Y div CAGR
44.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$988.8K
Annual income
$623,261.32
Full VICI calculator →

Portfolio growth — VINCW vs VICI

📍 VINCW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVINCWVICI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VINCW + VICI cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
VINCW pays
VICI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VINCW
Annual income on $10K today (after 15% tax)
$10,559.01/yr
After 10yr DRIP, annual income (after tax)
$3,293,769.96/yr
VICI
Annual income on $10K today (after 15% tax)
$558.67/yr
After 10yr DRIP, annual income (after tax)
$529,772.12/yr
At 15% tax rate, VINCW beats the other by $2,763,997.84/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VINCW + VICI for your $10,000?

VINCW: 50%VICI: 50%
100% VICI50/50100% VINCW
Portfolio after 10yr
$5.50M
Annual income
$2,249,142.40/yr
Blended yield
40.89%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VICI right now

VINCW
Analyst Ratings
1
Buy
Consensus: Buy
VICI
Analyst Ratings
20
Buy
6
Hold
Consensus: Buy
Price Target
$31.60
+16.5% upside vs current
Range: $30.00 — $33.00
Altman Z
1.4
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VINCW buys
0
VICI buys
0
No recent congressional trades found for VINCW or VICI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVINCWVICI
Forward yield124.22% ✓6.57%
Annual dividend / share$2.00 ✓$1.78
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%44.3% ✓
Portfolio after 10y$10.01M$988.8K ✓
Annual income after 10y$3,875,023.48 ✓$623,261.32
Total dividends collected$9.13M$948.4K ✓
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyBuy

Year-by-year: VINCW vs VICI ($10,000, DRIP)

YearVINCW PortfolioVINCW Income/yrVICI PortfolioVICI Income/yrGap
1← crossover$23,122$12,422.36$11,368$948.43+$11.8K → VINCW
2$51,585$26,844.33$13,339$1,493.16+$38.2K → VINCW
3$111,167$55,970.88$16,326$2,426.21+$94.8K → VINCW
4$231,676$112,727.29$21,123$4,112.15+$210.6K → VINCW
5$467,452$219,558.47$29,379$7,368.23+$438.1K → VINCW
6$914,194$414,020.78$44,804$14,191.64+$869.4K → VINCW
7$1,734,916$756,728.27$76,658$29,972.12+$1.66M → VINCW
8$3,198,495$1,342,134.90$150,894$71,015.81+$3.05M → VINCW
9$5,734,878$2,312,488.60$350,814$193,582.47+$5.38M → VINCW
10$10,011,343$3,875,023.48$988,809$623,261.32+$9.02M → VINCW

VINCW vs VICI: Complete Analysis 2026

VINCW — Stock

Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candidates include VIP217, an oral PTEFb/CDK9 inhibitor; VIP236, a small molecule drug conjugate to treat solid tumors; and VIP943 and VIP924 for the treatment of hematologic malignancies. Vincerx Pharma, Inc. was founded in 2019 is headquartered in Palo Alto, California.

Full VINCW Calculator →

VICI — REIT

VICI Properties is an experiential real estate investment trust that owns one of the largest portfolios of market-leading gaming, hospitality and entertainment destinations, including the world-renowned Caesars Palace. VICI Properties' national, geographically diverse portfolio consists of 29 gaming facilities comprising over 48 million square feet and features approximately 19,200 hotel rooms and more than 200 restaurants, bars and nightclubs. Its properties are leased to industry leading gaming and hospitality operators, including Caesars Entertainment, Inc., Century Casinos Inc., Hard Rock International, JACK Entertainment and Penn National Gaming, Inc. VICI Properties also owns four championship golf courses and 34 acres of undeveloped land adjacent to the Las Vegas Strip. VICI Properties' strategy is to create the nation's highest quality and most productive experiential real estate portfolio.

Full VICI Calculator →
📬

Get this VINCW vs VICI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VINCW vs SCHDVINCW vs JEPIVINCW vs OVINCW vs KOVINCW vs MAINVINCW vs NNNVINCW vs EPRTVINCW vs ADC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.